Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting. - Wikidata - wikimedia - TriplyDB

Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.

Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.

http://www.wikidata.org/entity/Q31114184

about

Imaging fungal infections in children β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)The epidemiology and diagnosis of invasive candidiasis among premature infants Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia.β-D-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Evaluation of a Novel Plasma (1,3)-β-d-Glucan Detection Assay for Diagnosis of Candidemia in Pediatric Patients Role of nutrients in the development of neonatal immune response.The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in Children Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.Managing fungal and viral infections in pediatric leukemia.Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.Invasive aspergillosis in children with acquired immunodeficiencies.Application of diagnostic markers to invasive aspergillosis in children.Invasive fungal infections in newborns and current management strategies.Invasive candidiasis and candidaemia in neonates and children: update on current guidelines.Improved detection of deeply invasive candidiasis with DNA aptamers specific binding to (1→3)-β-D-glucans from Candida albicans.Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children.Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients--is Aspergillus PCR appropriate?The Diagnostic Value of (1 → 3)-Beta-D-glucans and Galactomannan Assays in Children Suffering from Bacteremia in Pediatric Intensive Care Unit.Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.Progress in the Diagnosis of Invasive Fungal Disease in Children.Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections.Current Algorithms in Fungal Diagnosis in the Immunocompromised Host.Diagnosis of invasive fungal diseases in pediatric patients.Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.Case report of the reliability 1,3-β-D-glucan monitoring during treatment of peritoneal candidiasis in a child receiving continuous peritoneal dialysis Elevated serum beta-D-glucan levels in immunocompromised children with clinical suspicion for Pneumocystis jirovecii pneumonia (1-3)-β-D-glucan levels in candidiasis infections in the critically ill neonate.Pediatric Invasive Candidiasis: Epidemiology and Diagnosis in Children.Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis.Pediatric Invasive Aspergillosis.Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.Diagnostic Approaches for Invasive Aspergillosis-Specific Considerations in the Pediatric Population.Persistence of high-level (1,3)-β-D-glucan after candidemia following autologous peripheral SCT in a pediatric patient.Invasive Aspergillosis in Children: Update on Current Guidelines

P2860

Q26766376-F476B0D4-0E42-473F-91AD-DBA16B91440A Q26825753-F3F27AB7-B78C-494D-88E4-592FFB63583C Q26861652-081E6D77-6F00-4777-BC16-CC4A37ECD218 Q33711043-A9CA3BDC-9857-403A-A095-F40B0DFEE787 Q33825648-B70EB1F3-6E14-4E72-8719-A40A938F34AA Q34505582-0A4B6862-A678-4701-B965-7FC5F121D3D8 Q35297182-9E51679C-EB23-4F1C-B430-B5F244CD3438 Q35868758-DD0C045C-A9F6-4CFD-8D0B-8557596F8EBC Q35968648-3104A378-8B76-486C-BADB-0000F53F2A58 Q36051649-941E9D9A-226D-4981-9CA2-3783C22EEB73 Q36630700-9C4E7896-0248-45EA-9D97-7D27BACF9E2D Q36949545-E85F85A6-41D0-4068-A485-E1A5BB6928DB Q37810281-C30FC4D9-2BC8-4168-93B0-3B05E671CBDD Q37854718-4FA64F6D-184C-46C2-AF3F-9AABAD1F0D66 Q37954958-84261316-4A2C-41FA-BE8C-6F996A8B31B6 Q38066612-750D7233-85EC-4B3E-ABEE-FBA2A42FAA9E Q38119554-363165CA-2550-4A0D-8C81-EAB9C2885A9C Q38263282-ED569151-1898-4A7C-A6CF-C0E14E3A4DB2 Q38294178-01225A62-6B7D-4635-BF0A-20F4F13FD4F4 Q38611989-AAFA63F6-AC91-42A8-9B65-2B069FCB70A4 Q38693242-5F120A3E-C3E3-450F-AC8E-B482668EC526 Q39121179-B56E4290-EACD-4868-AC11-C9778C1A6A58 Q39175053-33C25EA8-7C60-45B3-8FF3-4B8CDC79BBBB Q39355509-255BD131-5F24-4252-A299-03F3F2760FC1 Q39416559-13264B5C-C11B-439C-B64D-CDCDD63A1CDC Q40266645-665178AF-123F-4BC9-B2E5-3304CA6D3CEE Q40454880-8E816B8A-6C51-49B8-9239-E18FD34D8F71 Q40524695-71EE6CF3-311A-44CE-852B-B10E31D5FFC4 Q41996456-E5A3AB02-421A-4011-A3B4-3373F358134A Q42559150-EDD11172-B875-4BF1-867C-B9568D7EFF70 Q42849189-91FBCACB-7435-4DD4-B217-5F52D128590E Q46253117-9C36DAF4-9B48-40EA-AE2E-3225EDE4623E Q49182676-0F91A9B4-74D9-4AF8-8E67-693F04286AB9 Q49612984-0E64C73C-1EBB-409C-ACBF-0BFE2C178CE0 Q49612998-35DECD25-89D8-43A8-8832-9E412B1598C8 Q50072321-4B94A013-EEFE-4453-AB72-6A506C305DDF Q52720488-5026D76B-D9FA-49EE-A70C-4C560AA0779A Q55460711-58A59F4C-8169-4663-A3D8-FD4793AA80AF Q58775551-EC35634A-7BB1-4BF7-BED2-9323B11D353F

P2860

Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.

http://www.wikidata.org/entity/Q31114184

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.

@ast

Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.

@en

type

label

Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.

@ast

Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.

@en

prefLabel

Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.

@ast

Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.

@en

P1433

Q31114184-05834142-562B-478B-99CA-17CCDB684C66

P1476

Q31114184-41920293-ADD1-4427-94EC-9EB979FFA3EF

P2093

Q31114184-1CF8D05D-AA6F-46DD-9975-46FE45FF5909

Q31114184-49A9A43C-10D3-4F59-A87B-D0CB18F3A4E5

Q31114184-725FB932-C67E-42C4-8C5A-EDD146039C6E

Q31114184-89F5B147-D290-44E6-89CB-E48715A61E31

Q31114184-E26EDEFE-C53C-447F-9090-03850A8A494D

P2860

Q31114184-103C6E51-8892-4037-8C70-54283FF8DDCB

Q31114184-16865C5F-BC79-4472-BD9D-198A9F31AE65

Q31114184-2CA0A449-B27E-4B8C-B4ED-95B5C96406E5

Q31114184-6F2A2B40-8655-435B-A46D-37CCA253A3A7

Q31114184-8CA67288-04A9-4D71-BA48-70A6C8707C89

Q31114184-D352D429-844F-4FA3-92C0-B35527BB103C

Q31114184-EE89F752-B05C-4B67-B3F8-FBC0490E43C9

Q31114184-F8A2513B-7A3F-476E-8777-2F1E849C2725

P304

Q31114184-FDBFC9D4-3C33-4758-A9F8-B4192EBD3EB1

P31

Q31114184-E801C892-E0C3-4AAC-AED5-06083525E4BB

P356

Q31114184-1FF5DD53-8981-4BB3-9DE5-E58173E8FAC9

P433

Q31114184-846B765F-4390-40D7-8BEF-DC7D12D843D8

P478

Q31114184-1D4F5EF8-68E7-4078-A193-C75C0191B97D

P50

Q31114184-E85BADD5-DC58-42D4-B83E-602CD56A816B

P577

Q31114184-344618EF-B74E-4B2E-8994-927ED4185A82

P5875

Q31114184-09FF7925-86A6-471F-9047-B5E1F315A00A

P698

Q31114184-27AB27E1-B53E-492C-BF8F-F7DE56734F10

P932

Q31114184-C261A7F9-EF3B-4031-98CA-BDFC06363E6C

P356

P1433

Clinical and Vaccine Immunology

P1476

Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.

@en

P2093

Barbara D Alexander

http://www.w3.org/2001/XMLSchema#string

Daniel K Benjamin

http://www.w3.org/2001/XMLSchema#string

Malcolm A Finkelman

http://www.w3.org/2001/XMLSchema#string

P Brian Smith

http://www.w3.org/2001/XMLSchema#string

William J Steinbach

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients

Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis.

Comparative study of mortality and morbidity in premature infants (birth weight, < 1,250 g) with candidemia or candidal meningitis.

Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques.

P304

924-925

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00025-07

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Melissa D. Johnson

P577

2007-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6298332

http://www.w3.org/2001/XMLSchema#string

P698

17538119

http://www.w3.org/2001/XMLSchema#string

P932

1951061

http://www.w3.org/2001/XMLSchema#string